Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Gallium 68 Citrate in Orthopedic Infections

NCT03123289 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03123289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Gallium 68 Citrate in Orthopedic Infections
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 2
Overall status
Terminated
Start date
March 6, 2017
Completion date
October 14, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

joint prosthesis